- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03443700
Randomized Controlled Trial on Robotic Exoskeleton in Spinal Cord Injury: Clinical Outcomes and Cortical Plasticity
Randomized Controlled Trial on Rehabilitation Training With a Robotic Anthropomorphic Exoskeleton in Patients With Motor Incomplete Spinal Cord Injury: Clinical Outcomes and Cortical Plasticity Indicators
The recent introduction of robotics for locomotor training in paraplegic patients, and in particular the use of anthropomorphic exoskeletons, has opened new frontiers in rehabilitation. Existing literature, though encouraging, is still scarce and studies demonstrating efficacy are highly heterogeneous and have a small sample size. Evidence is also needed about cortical plasticity after SCI, in conjunction with the use of innovative rehabilitation devices, through indicators like neurophysiological and neuroradiological markers, as the knowledge of such mechanisms is crucial to improve clinical outcomes. Cortical circuits controlling prosthetic devices are different from those controlling normal parts of the body and remodeling mechanisms following prosthetic use have been documented, but in conditions other than SCI.
The aims of this randomized controlled trial, with a 2-arm parallel-group design, are:
- to evaluate and quantify the efficacy of locomotor rehabilitation with a robotic anthropomorphic exoskeleton (EKSO-GT) in terms of clinical and functional outcomes, and the persistence of such efficacy;
- to investigate the presence and persistence of brain neuronal plasticity and cortical remodeling mechanisms underlying the robotic rehabilitation approach.
Fifty patients will be recruited and randomly assigned to 2 treatment arms. Both groups will follow a program of standard locomotor rehabilitation for 8 weeks. One group will also undergo an overground locomotor training with the EKSO-GT during the first 4 weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The increasing incidence of incomplete Spinal Cord Injury (SCI) has raised new rehabilitation challenges. Recovery of walking is one of the top priorities in SCI persons and growing efforts have been pursued aimed at identifying effective alternative techniques for improving gait performance.
Standard rehabilitation approach has been so far the most widely used, but the recent introduction of anthropomorphic exoskeletons may open new frontiers in the field. Anthropomorphic exoskeletons have been developed to assist SCI patients with mobility, but there is also a certain optimism that they may have potentialities to improve walking patterns of incomplete SCI persons after a rehabilitation period with such devices is terminated. So far, however, while different systematic reviews and meta-analyses have reported on the safety of the training with such exoskeletons, there are no significant Fiftystudies on its efficacy. Along with this, central mechanisms underlying the anatomical and functional changes induced by these approaches have never been investigated in SCI.
This longitudinal randomized controlled trial, with a 2-arm parallel group design, aims at evaluating the efficacy of the training with an anthropomorphic, robotized exoskeleton (EKSO-GT, by Ekso Bionics), as "add-on" to the standard locomotor rehabilitation, in improving walking performance, when compared to the standard locomotor rehabilitation alone, in a population of patients with non-acute motor incomplete SCI. Along with this and other clinical outcomes, neurophysiological and structural markers of Central Nervous System (CNS) plasticity will be explored, aimed at capturing mechanisms underlying how anthropomorphic exoskeletons affect CNS plasticity.
Fifty patients will be recruited in 3 Italian rehabilitation hospitals setting and assigned to 2 groups, with an allocation ratio of 1:1, through a block randomization approach. One group will perform a 4-week standard locomotor training (sLT) alone, while the other will perform a 4-week period sLT plus a training with the EKSO-GT (sLT + EX-T). Afterwards, both groups will undergo a further 4-week sLT alone.
Patients will be evaluated at several time points (always when the exoskeleton is not worn): clinical outcomes will be assessed by means of clinical examinations, standardized tests and validated scales; neurophysiological modulations will be evaluated by means of paired Motor and Sensory Evoked Potentials and a study of Electroencephalographic (EEG) slow waves oscillations and signal coherence during sleep; anatomical and structural cortical modifications will be studied with brain functional Magnetic Resonance Imaging (fMRI).
It is expected that the overground locomotor training with a new-generation exoskeleton, as "add-on" to standard locomotor training, can further improve clinical outcomes (especially walking performance) in the studied population, and that such clinical improvements are underlined by mechanisms modulating synaptic plasticity occurring also at the CNS level.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elena Antelmi, MD
- Phone Number: +39-3293526335
- Email: elenaantelmi@gmail.com
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40139
- Recruiting
- Azienda USL di Bologna, Istituto delle Scienze Neurologiche di Bologna (IRCCS ISNB)
-
Contact:
- Elena Antelmi, MD
- Phone Number: +39-3293526335
- Email: elenaantelmi@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- SCI due to traumatic or vascular etiology;
- Incomplete motor SCI (C or D in ASIA Impairment Scale);
- T1-L1 (included) neurological level;
- 1-5 years since injury;
- Functional gait ability (also with braces or orthoses);
- Sufficient Range of Motion (ROM) of lower limbs joints to achieve a reciprocal gait pattern and allow transition from sitting to vertical position;
- Stable clinical conditions;
- Minimum height of 157 cm;
- Maximum height of 188 cm;
- Maximum weight of 100 Kg;
- Maximum intertrochanteric distance of 46 cm;
- Cognitive integrity and full collaboration of the subject.
- Specific research informed consent signed.
Exclusion Criteria:
- Intensive walking rehabilitation training undergone in the last 3 months;
- Previous use of a robotic exoskeleton;
- Instability or major deformity of the spine;
- Lower limbs joints instability;
- Indication to spinal orthosis;
- Uncontrolled spasticity (score > 3 of the Modified Ashworth Scale) in the majority of the muscle groups of the lower limbs;
- History of traumatic brain injury;
- Recent significant bone fractures, traumatic and/or pathological for the required training;
- Presence of neurogenic paraosteoarthropathies (POAN) at the onset or phlogistic phase;
- Discrepancy in femurs length (> 1.3 cm) and legs length (> 1.9 cm);
- Symptomatic orthostatic hypotension;
- Severe and recurrent uncontrolled autonomic dysreflexia;
- Cardiopulmonary comorbidities limiting physical effort;
- Skin lesions that can interfere with the study rehabilitation trainings;
- Documented psychiatric pathology;
- Contraindications to fMRI and polygraphic EEG execution;
- Contraindications to TMS;
- Ongoing pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: sLT
Standard neurorehabilitation locomotor training during the whole study period (8 weeks).
|
Neurorehabilitation locomotor training will be performed according to standardized protocols shared within the scientific community, during the whole 8-week study period, 5 times per week, twice a day, for a total of about 2,5 hours per day.
|
Experimental: sLT + EX-T
Standard neurorehabilitation locomotor training (sLT) during the whole study period (8 weeks), plus a training with a new-generation robotic anthropomorphic exoskeleton (EKSO-GT locomotor training) during the first 4 study weeks.
|
Neurorehabilitation locomotor training will be performed according to standardized protocols shared within the scientific community, during the whole 8-week study period, 5 times per week, twice a day, for a total of about 2,5 hours per day.
Each rehabilitation session with EKSO-GT will last (operating time) 30-40 minutes.
Such training will be carried out for 3 sessions per week, during the first 4 consecutive weeks of the study period (i.e. 12 total sessions per patient).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in walking performance
Time Frame: Baseline (initial visit post-randomization); week 4
|
10-meter walk test
|
Baseline (initial visit post-randomization); week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in walking performance
Time Frame: Baseline (initial visit post-randomization); week 8
|
10-meter walk test
|
Baseline (initial visit post-randomization); week 8
|
Change in walking endurance
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
6-minute walk test
|
Baseline (initial visit post-randomization); week 4; week 8
|
Change in functional walking capacity
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
Walking Index for Spinal Cord Injury II (WISCI II)
|
Baseline (initial visit post-randomization); week 4; week 8
|
Change in spasticity
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
Modified Ashworth Scale
|
Baseline (initial visit post-randomization); week 4; week 8
|
Change in pain
Time Frame: Baseline (initial visit post-randomization); every day, twice a day for the whole study period; overall appraisal at week 4 and week 8
|
Numeric Rating Scale (NRS)
|
Baseline (initial visit post-randomization); every day, twice a day for the whole study period; overall appraisal at week 4 and week 8
|
Change in mood state
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
Profile of Mood States questionnaire (POMS)
|
Baseline (initial visit post-randomization); week 4; week 8
|
Change in lower limbs muscle strength
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
Lower Extremity Motor Score (LEMS) of the American Spinal Injury Association (ASIA) Impairment Scale
|
Baseline (initial visit post-randomization); week 4; week 8
|
Change in lower limbs muscle activation pattern
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
Gait Dynamic Electromyography (DEMG)
|
Baseline (initial visit post-randomization); week 4; week 8
|
Change in entity of neuronal plasticity and cortical remodelling of motor cortical areas
Time Frame: Baseline (initial visit post-randomization); after the first locomotor training session; week 4; week 8
|
Change in short-term intracortical inhibition through Motor Evoked Potentials (PEMs) elicited by Transcranial Magnetic Stimulation (TMS)
|
Baseline (initial visit post-randomization); after the first locomotor training session; week 4; week 8
|
Change in entity of neuronal plasticity and cortical remodelling of sensory cortical areas
Time Frame: Baseline (initial visit post-randomization); after the first locomotor training session; week 4; week 8
|
Somatosensory Evoked Potentials (SSEs) at cortical level
|
Baseline (initial visit post-randomization); after the first locomotor training session; week 4; week 8
|
Change in synaptic potentiation (neuroprosthetic learning)
Time Frame: Baseline (initial visit post-randomization); after the first locomotor training session; week 4
|
Analysis of slow-wave oscillations with Electroencephalographic (EEG) polysomnography (PSG)
|
Baseline (initial visit post-randomization); after the first locomotor training session; week 4
|
Change in synaptic potentiation (neuroprosthetic learning)
Time Frame: Baseline (initial visit post-randomization); after the first locomotor training session; week 4
|
Analysis of EEG coherence signal
|
Baseline (initial visit post-randomization); after the first locomotor training session; week 4
|
Change in brain anatomy and cortical structure
Time Frame: Baseline (initial visit post-randomization); week 4; week 8
|
Functional Magnetic Resonance Imaging (fMRI)
|
Baseline (initial visit post-randomization); week 4; week 8
|
Evaluation of patient's satisfaction for the training received
Time Frame: Week 4
|
Ad-hoc questionnaire
|
Week 4
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elena Antelmi, MD, IRCCS - ISNB
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CE-19072
- 347-2019-DISP-AUSLBO (Other Identifier: CE AVEC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
InVivo TherapeuticsTerminated
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Epidural Spinal Cord CompressionUnited States
Clinical Trials on Standard neurorehabilitation locomotor training
-
IRCCS San Camillo, Venezia, ItalyUnknown
-
Hugo W. Moser Research Institute at Kennedy Krieger...Terminated
-
National Institute of Neurological Disorders and...Completed
-
Stony Brook UniversityOhio State University; University of Louisville; TIRR Memorial Hermann; Kessler... and other collaboratorsCompletedSpinal Cord Injuries | Spinal Cord TraumaUnited States
-
US Department of Veterans AffairsCompleted
-
University of MiamiEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSpinal Cord Injury
-
University of LouisvilleThe Leona M. and Harry B. Helmsley Charitable Trust; Kosair Charities, Inc.Active, not recruiting
-
Istanbul Kültür UniversityIstanbul University - Cerrahpasa (IUC)Active, not recruitingMultiple Sclerosis | Vestibular Rehabilitation | 3D Gait AnalysisTurkey
-
University of ZurichFoundation Wings For LifeCompletedGait Disorders, Neurologic | Gait Disorder, SensorimotorSwitzerland
-
University Hospital of Mont-GodinneUniversité Catholique de LouvainUnknownBimanual Training in Children With Hemiplegia With Lower Limb and Postural Stimulation (HABIT & Leg)Congenital HemiplegiaBelgium